ARPA-H awards more than $100M to biosensor development projects

Four organizations will develop devices for tracking heart disease, inflammation and perimenopause.

By Nick Paul Taylor • Oct. 5, 2026

Edwards’ adjustable heart valve for children lands FDA approval

The device could help young patients avoid multiple open-heart surgeries as they grow, FDA officials said.

By Susan Kelly • Oct. 2, 2026

Explore the Trendline➔

New medical devices are reshaping the medtech industry

From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

By MedTech Dive staff

Medtronic reveals cardiac mapping and ablation software clearances

The regulatory authorizations come as Medtronic looks to differentiate itself in the fast-growing pulsed field ablation market targeted by rivals Abbott, Boston Scientific and J&J.

By Nick Paul Taylor • Oct. 1, 2026

Intuitive expands push into cardiac market with CE mark

After de-emphasizing heart surgery for decades due to limits with its earlier platforms, the surgical robot maker is eyeing the large market in cardiovascular disease treatment.

By Susan Kelly • Sept. 25, 2026

CVRx names John Landry as CFO

Landry joins in the aftermath of an investor’s call for the sale of the heart failure device company.

By Nick Paul Taylor • Sept. 23, 2026

Cordis wins FDA approval for sirolimus-eluting balloon

The approval gives physicians an alternative to uncoated balloons and Boston Scientific’s paclitaxel-coated device.

By Nick Paul Taylor • Sept. 22, 2026

Recor Medical ex-CEO Lara Barghout joins Medtronic

Barghout, who led Recor when it won FDA approval of the first renal denervation treatment for hypertension, is the new president of Medtronic’s Interventional Cardiology Therapies business.

By Susan Kelly • Sept. 16, 2026

J&J sells Laminar LAA closure assets it bought 3 years ago

The decision is part of J&J’s strategy to prioritize resources for the greatest impact and positions Laminar for success under dedicated ownership, a spokesperson said.

By Susan Kelly • Sept. 16, 2026

CMS expands TAVR Medicare coverage to asymptomatic patients

The Centers for Medicare and Medicaid Services’ policy update extends Medicare coverage to severe aortic stenosis patients without symptoms, a change that analysts said will especially benefit Edwards Lifesciences.

By Susan Kelly • Sept. 11, 2026

ARPA-H to award $62.7M for AI in cardiovascular care

Companies including Tempus AI and Updoc are tasked with building an agentic AI system for managing heart failure.

By Elise Reuter • Sept. 11, 2026

Abbott wins FDA approval for dual-energy ablation catheter

CEO Robert Ford has said the atrial fibrillation treatment, along with the company's Volt PFA device, is expected to help Abbott regain market share in electrophysiology.

By Susan Kelly • Sept. 8, 2026

Elucid raises $55M to commercialize cardiovascular imaging platform

Elucid, which gained a large medtech company as an investor, plans to grow industry partnerships as it looks to expand its AI-powered imaging platform.

By Nick Paul Taylor • Sept. 8, 2026

Abbott ablation device effective at 1 year in complex cases

Abbott said it will use the study results to secure FDA approval for the TactiFlex Duo catheter that offers both PFA and RF energy for tailoring treatment of atrial fibrillation.

By Susan Kelly • Sept. 2, 2026

GE HealthCare secures CE mark for photon-counting CT device

GE HealthCare is challenging Siemens Healthineers in the market for a technology that is designed to provide clearer images than traditional CT systems.

By Nick Paul Taylor • Sept. 1, 2026

Boston Scientific discontinues angiographic catheters

The company plans to stop selling its Imager II Angiographic Catheters after a manufacturing problem led the company to pull the devices from the market.

By Elise Reuter • Updated Aug. 31, 2026

Kardium receives $31M investment from Canada for manufacturing expansion

The company received FDA approval for its pulsed field ablation system last year and closed a $250 million funding round.

By Nick Paul Taylor • Aug. 31, 2026

Abbott wins CE mark for new LAA closure device

Abbott is aiming to capture share from Boston Scientific in the market for devices that seal the heart’s left atrial appendage to reduce stroke risk.

By Susan Kelly • Aug. 28, 2026

J&J’s latest Impella recall tied to 3 deaths, 37 injuries

Hospitals can use automated controllers in inventory while waiting for service from J&J’s Abiomed business to ensure patients who need Impella heart pumps can still receive care.

By Susan Kelly • Aug. 27, 2026

Medtronic veteran departs for CEO role at heart valve startup

Bill Shields, who led transcatheter mitral and tricuspid therapies at Medtronic, has joined Versa Vascular, developer of a valve repair treatment.

By Susan Kelly • Aug. 12, 2026

IRhythm grows heart monitoring leadership with $288M VitalConnect buy

Acquiring VitalConnect could unlock a $1 billion cardiac monitoring market that is only partly served by iRhythm’s existing devices.

By Nick Paul Taylor • Aug. 10, 2026

Philips forms 6 patient monitoring partnerships

By employing wearable devices to support patient monitoring between the hospital and home, Philips hopes to improve care continuity.

By Nick Paul Taylor • Aug. 7, 2026

Medtronic gets CE mark for ablation to treat ventricular tachycardia

Older ablation approaches for ventricular tachycardia have been suboptimal, Medtronic said. The company plans to bring a more effective treatment for the life-threatening heart condition.

By Susan Kelly • Aug. 7, 2026

Caristo wins FDA authorization for cardiovascular risk predictor

The University of Oxford spinout will soon launch the AI tool, which research suggests could help assess heart attack risk in patients who don’t have obstructive coronary artery disease.

By Nick Paul Taylor • Aug. 4, 2026

Siemens Healthineers, Cleveland Clinic form 10-year alliance

The deal to provide a range of imaging and therapeutic technologies to Cleveland Clinic extends the partners’ longtime relationship and follows a recent 10-year pact between Siemens Healthineers and Mayo Clinic.

By Nick Paul Taylor • July 31, 2026

Medtronic leads $37M investment in ablation mapping startup CoreMap

Medtronic has backed CoreMap to address a critical unmet need in atrial fibrillation treatment.

By Nick Paul Taylor • July 30, 2026